{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:49:50Z","timestamp":1773384590674,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T00:00:00Z","timestamp":1378252800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068223","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T17:11:55Z","timestamp":1378314715000},"page":"e68223","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Circadian Variation in Anti-M\u00fcllerian Hormone in Patients with Polycystic Ovary Syndrome Differs Significantly from Normally Ovulating Women"],"prefix":"10.1371","volume":"8","author":[{"given":"Leif","family":"Bungum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Franssohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Bungum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Giwercman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:30:1:1","article-title":"Polycystic ovarian syndrome: insights into the enigma that is PCOS today","volume":"30","author":"HJ Teede","year":"2006","journal-title":"Endocrine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"S Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00001703-199404000-00005","article-title":"Advances in induction of ovulation","volume":"6","author":"S Franks","year":"1994","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref4","first-page":"S30","article-title":"[Ovary stimulation without IVF in polycystic ovary syndrome]","volume":"32","author":"D Dewailly","year":"2003","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0039-128X(98)00035-X","article-title":"Etiology of anovulation in polycystic ovary syndrome","volume":"63","author":"S Franks","year":"1998","journal-title":"Steroids"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"DA Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"ref7","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"J Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/ENDO:30:1:45","article-title":"Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS","volume":"30","author":"HJ Teede","year":"2006","journal-title":"Endocrine"},{"key":"ref9","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries","volume":"79","author":"C Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0188-4409(01)00325-3","article-title":"Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome","volume":"32","author":"M Barontini","year":"2001","journal-title":"Arch Med Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000160911","article-title":"Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients","volume":"89","author":"M Moret","year":"2009","journal-title":"Neuroendocrinology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-64-1-180","article-title":"The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans","volume":"64","author":"JE Nestler","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2007-2656","article-title":"Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women","volume":"93","author":"MA Lawson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI113864","article-title":"Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome","volume":"83","author":"A Dunaif","year":"1989","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2004-1040","article-title":"Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment","volume":"90","author":"RV Mehta","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"JE Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0889-8529(05)70073-6","article-title":"Insulin action in the polycystic ovary syndrome","volume":"28","author":"A Dunaif","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"KA Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"ref19","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"D Willis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0015-0282(16)55797-5","article-title":"Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome","volume":"59","author":"TD Pache","year":"1993","journal-title":"Fertil Steril"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/deg115","article-title":"Ultrasound examination of polycystic ovaries: is it worth counting the follicles?","volume":"18","author":"S Jonard","year":"2003","journal-title":"Hum Reprod"},{"key":"ref22","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"CA Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jcem-72-6-1206","article-title":"Effect of recombinant activin on androgen synthesis in cultured human thecal cells","volume":"72","author":"SG Hillier","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1083-3188(96)70002-5","article-title":"Polycystic ovarian disease: current insights into an old problem","volume":"9","author":"LC Udoff","year":"1996","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"P Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"VL Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-Mullerian hormone: a new marker for ovarian function","volume":"131","author":"JA Visser","year":"2006","journal-title":"Reproduction"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"JS Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"T Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(97)81417-3","article-title":"Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis","volume":"67","author":"ME Fallat","year":"1997","journal-title":"Fertil Steril"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/humrep\/deq380","article-title":"Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels","volume":"26","author":"L Bungum","year":"2011","journal-title":"Hum Reprod"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"R Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"RJ Norman","year":"2007","journal-title":"Lancet"},{"key":"ref34","first-page":"356","article-title":"[Study on the anti-mullerian hormone served as a marker for granulosa cell tumor of ovary]","volume":"35","author":"W Long","year":"2000","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"A Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2002-36706","article-title":"Regulation of gonadotropin secretion: implications for polycystic ovary syndrome","volume":"20","author":"CR McCartney","year":"2002","journal-title":"Semin Reprod Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"SK Blank","year":"2006","journal-title":"Hum Reprod Update"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"R Tsutsumi","year":"2009","journal-title":"Endocr J"},{"key":"ref39","first-page":"1318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"AJ Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7827-10-36","article-title":"Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome","volume":"10","author":"N Liu","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1677\/joe.0.1450535","article-title":"Developmental regulation of androgen receptor in rat ovary","volume":"145","author":"M Tetsuka","year":"1995","journal-title":"J Endocrinol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"J Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/me.2002-0186","article-title":"Follicle-stimulating hormone increases testicular Anti-Mullerian hormone (AMH) production through sertoli cell proliferation and a nonclassical cyclic adenosine 5\u2032-monophosphate-mediated activation of the AMH Gene","volume":"17","author":"C Lukas-Croisier","year":"2003","journal-title":"Mol Endocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/endo-127-4-1825","article-title":"Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes","volume":"127","author":"T Kuroda","year":"1990","journal-title":"Endocrinology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"CL Cook","year":"2002","journal-title":"Fertil Steril"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.fertnstert.2009.10.006","article-title":"Serum AMH, FSH, and LH levels in PCOS","volume":"93","author":"N Georgopoulos","year":"2010","journal-title":"Fertility and Sterility"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mehy.2011.07.005","article-title":"Serum anti-Mullerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels","volume":"77","author":"D Panidis","year":"2011","journal-title":"Med Hypotheses"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"A Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fertnstert.2005.02.017","article-title":"Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome","volume":"84","author":"D Panidis","year":"2005","journal-title":"Fertil Steril"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Georgopoulos NA, Saltamavros AD, Decavalas G, Piouka A, Katsikis I, <etal>et al<\/etal>.. (2010) Serum AMH, FSH, and LH levels in PCOS. Fertil Steril 93: e13; author reply e14.","DOI":"10.1016\/j.fertnstert.2009.10.006"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/09513590.2010.507283","article-title":"The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia","volume":"27","author":"D Panidis","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1203\/00006450-197802000-00015","article-title":"Increased secretion of Mullerian inhibiting substance after immunological blockade of endogenous luteinizing hormone releasing hormone in the rat","volume":"12","author":"BB Bercu","year":"1978","journal-title":"Pediatr Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1073\/pnas.1633592100","article-title":"Regulation of gonadotropin gene expression by Mullerian inhibiting substance","volume":"100","author":"GY Bedecarrats","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","first-page":"1664","article-title":"Diurnal rhythm in serum levels of inhibin B in normal men: relation to testicular steroids and gonadotropins","volume":"84","author":"E Carlsen","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T05:17:35Z","timestamp":1563859055000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068223"}},"subtitle":[],"editor":[{"given":"Samuel","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,4]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068223","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,4]]}}}